CURAIZON Has potential Market

Every man needs medical assistance, to say a person or an organization of folks are completely healthy is a fallacy, the amount of an individual’s primary health issues ranges from mild to severe. Quite often than nothing, it is in the real human nature never to seek medical assistance until the health becomes severe.

CURAIZON is a UK-based company that has provided answers to improve patients’ adherence to drugs. CURAIZON developed an ecosystem (CuraServe™, CuraData™, and CuraView™) which can only help reduce the price tag on seeking health care and improve medical research. To be able to raise the rate of drug adherence, Curaizon will continue to work with patients and their own families and professional medical providers to guarantee the success of the answer that Curaizon provides. When patients see a doctor using their medical complaints, they are signed up for CuraServe™ within the treatment. CuraServe™ delivers notifications to these patients and welcomes those to the service. Also, it means that patients take their medications as approved by mailing notifications that remind them to use their medications. CuraServe™ also designates an in-depth relative(s) to ensure that the patients take their medication in the event they forgot. These patients are encouraged for taking their drugs as approved because they are given the possibility to decide on a charity home to get small donations every time they take their drugs as designed. CuraData™ collects demographic, and adherence data from patients signed up for the CuraServe™ service. The info made from a patient’s adherence to medications are created open to the patient’s doctor instantly so that he could assess the patient’s adherence rate to be able to make alterations to the procedure and help the individual assume maximum health. This reviews mechanism is manufactured possible with Curaizon’s Curaview™. Curaizon markets its compliance alternatives (Cura Help ) to countrywide health services worldwide. Our customers are healthcare patients who take any form of medication. We also use industry academia, pharmacy and biotechnology, and also other data users through our Cura Data solution. The extensive amount of unique and valuable data we accumulate through CuraServe funds home in CuraData. Our bodies merge the info we accumulate through our real-time compliance solutions with the patient's data. This data is stored of-chain onto an AES 256 encrypted cloud within an appropriate geographic area with the blockchain saving ideas and guidelines to gain access to and utilization which becomes the area of the CuraData.

It could be accessed whatever the health service or EMR used Healthcare providers benefit from Big Data if indeed they have a more holistic, patient-centered method of value; the one which focuses evenly on health-care spending and treatment benefits. This is permitted through the info and analytics of Curaizon’s data. By overlaying the adherence data CuraServe™ produces, we're able to quantify the efficacy and sustainability of every drug a patent assumes a personal basis. This information may be used to create an optimum drug strategy and dramatically improve final patent results while also keeping health services tens of vast amounts of dollars.

Our data solutions will support better prescription suggestions, increase drug development, enable early on intervention by doctors, help develop better treatments for chronic and long-term diseases, identify best and worst practices and permit efficiency by matching the right drug to the right patent based after actual results.

Curaizon can reduce misuse and keep patients healthy and from the medical center. We do that by participating them as a stakeholder in their treatment. As technology has an ever-greater role in health care, patent benefits, quality of treatment, efficiency and lifespan will all improve. Every time that people help a patent take their medication, we lower overall professional medical costs and invite licenses to business lead more comfortable and healthier lives. Curaizon is a driving power in this objective.

For more detailed information about the project, I recommend to visit the links below: